Deborah Pajalunga, PhD
Affiliations: | 2000-2002 | Laboratory of Cellular and Molecular Biology | National Cancer Institue-NIH |
| 2003- | Faculty of Medicine | University of Rome La Sapienza, Roma, Lazio, Italy |
Google:
"Deborah Pajalunga"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cecchi F, Pajalunga D, Fowler CA, et al. (2012) Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling. Cancer Cell. 22: 250-62 |
| Cecchi F, Pajalunga D, Fowler A, et al. (2011) A hepatocyte growth factor antagonist engineered by site-directed mutagenesis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 10528 |
| Cecchi F, Pajalunga D, McNeil B, et al. (2010) Abstract SY23-03: Oncogenic signal transduction via the hepatocyte growth factor/Met receptor kinase pathway Cellular and Molecular Biology |
| Cecchi F, Pajalunga D, Rabe DC, et al. (2010) Abstract 342: A hepatocyte growth factor antagonist engineered by disruption of heparan sulfate binding Cancer Research. 70: 342-342 |
| Cecchi F, Pajalunga D, Rabe D, et al. (2009) Abstract B228: A hepatocyte growth factor antagonist engineered by targeted disruption of heparan sulfate binding Molecular Cancer Therapeutics. 8 |